Market Overview The specialty pharmaceuticals market is transitioning toward value-based pricing and outcomes-based contracts that align pharmaceutical costs with demonstrated clinical benefit, addressing payer concerns about budget impact and sustainability. Traditional volume-based pricing models are increasingly untenable for therapies costing hundreds of thousands of dollars annually,...